Bilobalide (BB), ginkgolide B (GB), diltiazem (DTZ), and picrotoxinin (PXN) are 5-hydroxytryptamine type 3 (5-HT 3 ) receptor antagonists in which the principal sites of action are in the channel. To probe their exact binding locations, 5-HT 3 receptors with substitutions in their pore lining residues were constructed (NϪ4ЈQ, EϪ1ЈD, S2ЈA, T6ЈS, L7ЈT, L9ЈV, S12ЈA, I16ЈV, D20ЈE), expressed in Xenopus laevis oocytes, and the effects of the compounds on 5-HT-induced currents were examined. EC 50 values at mutant receptors were less than 6-fold different from those of wild type, indicating that the mutations were well tolerated. BB, GB, DTZ, and PXN had pIC 50 values of 3.33, 3.14, 4.67, and 4.97, respectively. Inhibition by BB and GB was abolished in mutant receptors containing T6ЈS and S12ЈA substitutions, but their potencies were enhanced (42-and 125-fold, respectively) in S2ЈA mutant receptors. S2ЈA substitution also caused GB ligand trap. PXN potency was modestly enhanced (5-fold) in S2ЈA, abolished in T6ЈS, and reduced in L9ЈV (40-fold) and S12ЈA (7-fold) receptors. DTZ potency was reduced in L7ЈT and S12ЈA receptors (5-fold), and DTZ also displaced [3 H]granisetron binding, indicating mixed competitive/noncompetitive inhibition. We conclude that regions close to the hydrophobic gate of M2 are important for the inhibitory effects of BB, GB, DTZ, and PXN at the 5-HT 3 receptor; for BB, GB, and PXN, the data show that the 6Ј channel lining residue is their major site of action, with minor roles for 2Ј, 9Ј, and 12Ј residues, whereas for DTZ, the 7Ј and 12Ј sites are important.